MAB2629

antibody from Novus Biologicals

Targeting: FGF23

Western blot (Data presented on provider website)

Antibody Data

Product number

MAB2629

Provider

Novus Biologicals

Product name

Rat Monoclonal FGF-23 Antibody

Antibody type

Monoclonal

Description

Protein A or G purified from hybridoma culture supernatant. Detects human and mouse FGF-23 in direct ELISAs and Western blots. Does not cross-react with recombinant human (rh) FGF acidic, rhFGF basic, rhFGF-3, -4, -5, -6, -7, -9, -10, -11, -12, -13, -16, -17, -18, -19, -20, -21, recombinant mouse (rm) FGF-8b, rmFGF-8c, or rmFGF-15.

Reactivity

Human, Mouse

Host

Rat

Isotype

IgG

Vial size

100 ug

Concentration

LYOPH

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

References

Submitted references

Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23.

Quarto N, Shailendra S, Meyer NP, Menon S, Renda A, Longaker MT
Frontiers in physiology 2018;9:1426

---

FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.

Smith ER, Tan SJ, Holt SG, Hewitson TD
Scientific reports 2017 Jun 13;7(1):3345

---

Osteocyte-specific deletion of Fgfr1 suppresses FGF23.

Xiao Z, Huang J, Cao L, Liang Y, Han X, Quarles LD
PloS one 2014;9(8):e104154

---

Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period.

Takaiwa M, Aya K, Miyai T, Hasegawa K, Yokoyama M, Kondo Y, Kodani N, Seino Y, Tanaka H, Morishima T
Bone 2010 Aug;47(2):256-62